Monoclonal Antibodies (MAbs) for Prevention and Treatment of COVID-19

Viewpoint discusses potential role of MAbs as a means of prevention in high-risk populations. It also raises possible limitations of the approach that need to be disproven or addressed for the strategy to be effective.

Source:

Journal of the American Medical Association